Research on HIV/AIDS Drug Resistance

Overviews | HIV Mutations | Resistance Risk | Resistance Testing

Overviews

NNRTI Resistance Found in 12% of People Stopping Treatment With Undetectable Viral Load: Implications for Stock-Outs (March 24, 2014)
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
Transmitted HIV Resistance Rate Close to 20% in Large Study of U.S. MSM (March 5, 2014)
From National AIDS Treatment Advocacy Project
Most MSM Who Transmit Drug-Resistant HIV Aren't on Treatment, Swiss Study Reports (November 22, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
On TheBodyPRO.com
Persistence of Transmitted Drug Resistance Mutations Suggests Source Partners May Be Treatment-Naive (September/October 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
Number of People Infected With Drug-Resistant HIV in Europe Has Risen by Around 35% (October 17, 2013)
From aidsmap.com
Transmitted NNRTI Resistance Rate Climbing in U.S. but Flat in Big European Countries (July 24, 2013)
From National AIDS Treatment Advocacy Project
Transmitted Antiretroviral Drug Resistance Holds Steady at 16% (Video) (March 25, 2013)
From HIVandHepatitis.com
California: Studying Drug-Resistant HIV in Los Angeles County (March 19, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
On TheBodyPRO.com
Eradication/Cure, Prevention, Novel Strategies for Administration of PrEP (Delivery Alternatives), Antiretroviral Therapy/Drug Resistance/New Drugs/Comorbidities (March 17, 2013)
From National AIDS Treatment Advocacy Project
Resistance to Darunavir Falling Since Approval of the Protease Inhibitor in 2006 (March 11, 2013)
From National AIDS Treatment Advocacy Project

VIEW ALL ARTICLES

Resistance Risk

Taking PrEP Does Not Increase Drug Resistance Risk (May 30, 2014)
From TheBodyPRO.com
Some Children With HIV Grow Resistant to Drugs, Says Study (April 25, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
On TheBodyPRO.com
IRIN/PlusNews Examines Threat of HIV Drug-Resistance in Africa (September 13, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
Protease Inhibitor to Raltegravir Switch Maintains Viral Suppression, but NRTI Resistance Lowers Efficacy (July 22, 2010)
From aidsmap.com
On TheBodyPRO.com
Researchers Develop Questions to Determine Risk of HIV/AIDS Drug Resistance (May 19, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
Sudden Drop Observed in Transmitted HIV Drug Resistance Among Cohort of Recently Infected San Francisco Patients (February 10, 2009)
Vivek Jain, M.D., presents data from a cohort of 266 patients with acute and early HIV infection, among whom a sudden drop in the prevalence of transmitted HIV drug resistance occurred in 2008 -- dramatically reversing a general upward trend over the previous four years.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Regimens With Boosted Protease Inhibitors Are the Most Resistance-Proof, Study Finds (May 22, 2008)
In The Journal of Infectious Diseases
Drug Use During Sex May Make Infection With Drug-Resistant HIV More Likely (May 20, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from CDC National Prevention Information Network
Consequences of Non-Adherence Worse in African-Americans than White People (December 16, 2007)
From aidsmap.com
First-Line Triple-Combination Antiretroviral Therapy Provides Long-Term Protection Against AIDS-Related Illnesses, Study Says (December 10, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

VIEW ALL ARTICLES

Research on Drug Resistance: 1996-1998

Highlights From the Resistance Workshop (August/September 1998)
A report from the 12th World AIDS Conference.
In TAGline, from Treatment Action Group
Mechanisms of Antiretroviral Therapy Failure: Resistance (May 1, 1998)
In The 8th Clinical Care Options for HIV Symposium, from TheBodyPRO.com
Emergence of HIV-1 Resistance in Seminal Plasma of Men on Antiretroviral Therapy (February 4, 1998)
In The 5th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
First Test for HIV Resistance to Nucleoside Analogs Is Available (December 1997)
In HIV Newsline, from San Francisco General Hospital
Clinical Implications of Resistance to Antiretroviral Drugs (November 21, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
Update From the June 1997 International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication (November 7, 1997)
From U.S. National Institute of Allergy and Infectious Diseases
Is Resistance Always a Bad Thing? (June 1997)
In HIV Newsline, from San Francisco General Hospital
Viral Resistance (report from the XIth International AIDS Conference) (Summer 1996)
In STEP Perspective, from Seattle Treatment Education Project